PDK1 and cancer: Altered expressions of the PDK family members (PDK1–4) have been noticed in various types of malignant tumors, which are related to tumor proliferation, invasion, anti-apoptosis, and therapy resistance [64,65,66,67,68,69,70] (Figure 3).